Cargando…
An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Vaccine Clinical Trials
PURPOSE: Despite being among those most in need of protection, frail older adults are often not well represented in clinical trials. Although frailty likely influences responses to treatments and vaccines, frailty may not be explicitly considered in trials even when frail participants are enrolled d...
Autores principales: | Andrew, Melissa K, Matthews, Sean, Kim, Joon Hyung, Riley, Megan E, Curran, Desmond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397533/ https://www.ncbi.nlm.nih.gov/pubmed/36017192 http://dx.doi.org/10.2147/CIA.S364997 |
Ejemplares similares
-
18. An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Clinical Trials
por: Andrew, Melissa K, et al.
Publicado: (2021) -
5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies
por: Andrew, Melissa K, et al.
Publicado: (2020) -
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials
por: Curran, Desmond, et al.
Publicado: (2022) -
Evaluation of two frailty indices, with practical application in a vaccine clinical trial
por: Curran, Desmond, et al.
Publicado: (2019) -
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals
por: Curran, Desmond, et al.
Publicado: (2020)